Brief: Galectin Therapeutics Reports 2022 Loss Per Share Of $0.65
30/03/2023 14:41
March 30 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS REPORTS 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
* GALECTIN THERAPEUTICS INC FY LOSS PER SHARE $0.65
* GALECTIN THERAPEUTICS INC - AS OF DEC 31, 2022, CO HAD
$18.6
MILLION OF CASH AND CASH EQUIVALENTS
* GALECTIN THERAPEUTICS INC - EXPECTS IT WILL REQUIRE MORE
CASH TO
FUND OPERATIONS AFTER DEC 31,
Source text for Eikon: ID:nGNX7J58DW
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study